Codexis, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Codexis, Inc. (CDXS) on June 20, 2019. The filing reports the entry into a material definitive agreement and the unregistered sale of equity securities on the same date.
Key Financial Metrics and Transaction Details
- Transaction Type: Private placement of common stock.
- Investor: An affiliate of Casdin Capital, LLC (Casdin Partners Master Fund, L.P.).
- Shares Issued: 3,048,780 shares of common stock.
- Price Per Share: $16.40.
- Gross Proceeds: Approximately $50.0 million.
- Exemption: The offering was exempt from registration under Section 4(a)(2) of the Securities Act and Regulation D.
Material Changes and Agreements
The Company entered into a Securities Purchase Agreement and a Registration Rights Agreement with the Investor. Under the Registration Rights Agreement, Codexis agreed to file a registration statement with the SEC within 180 days (or 210 days if not a "well-known seasoned issuer") to register the resale of the shares. The Company also agreed to indemnify the selling holders and pay associated fees and expenses, excluding underwriting discounts.
Guidance, Outlook, and Risks
The filing does not provide specific financial guidance, revenue outlook, or management commentary regarding future operations beyond the announcement of the capital raise. The primary risk noted is that the shares are unregistered and may not be offered or sold in the United States absent registration or an applicable exemption.
Key Facts for Investor Verification
- Verify the dilution impact of the issuance of 3,048,780 new shares on existing shareholders.
- Confirm the intended use of the approximately $50.0 million in gross proceeds as detailed in the accompanying press release (Exhibit 99.1).
- Monitor the timeline for the filing of the registration statement for the resale of shares, which is due within 180 to 210 days of June 20, 2019.
- Review the full text of the Securities Purchase Agreement (Exhibit 10.1) for any specific covenants or restrictions imposed on the Company.